Discover the most recent news about our Company.
Nuclear Magnetic Resonance (NMR) metabolomics emerges as a promising tool in HIV research due to its ability to provide a
In an effort to contribute to the fight against cancer, Biosfer Teslab has actively participated in ‘Lliga’t a la Vida,’
Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular
Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein
On Monday, October 16, 2023, our CEO Núria Amigó participated in the event “Empowering the Future We Want” alongside Jose
The size of LDL lipoproteins varies and is dependent on the lipid content they carry inside, which in turn influences
Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by
NMR metabolomics & AI in neonatal health Did you know that there are almost 3 million fetal and neonatal deaths every
Biosfer Teslab asiste a la International Manuel Rico NMR School From June 19th to 23rd, the XV edition of the
Spring Highlights: international actions, conferences, and courses Biosfer Teslab a leading innovator in metabolomic based health applications and NMR services,
Swiss Biotech Day 24 y 25 de abril de 2023 Last 24th and 25th April, the Swiss Biotech Day took
Metabolomics: Personalised precision medicine is here With omics technologies we can obtain a more objective and complete view of the
